DRUG Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Bright Minds Biosciences Inc (DRUG) Moving Averages Convergence Divergence (MACD) indicator is -0.959, suggesting DRUG is Sell.

Bright Minds Biosciences Inc (DRUG) 20-Day simple moving average is 81.989, while Bright Minds Biosciences Inc (DRUG) share price is $75.83, making it Sell.

Bright Minds Biosciences Inc (DRUG) 60-Day simple moving average is 83.066, while Bright Minds Biosciences Inc (DRUG) share price is $75.83, making it Sell.

Technical Analysis for DRUG

Technical Sentiment Analysis for Bright Minds Biosciences Inc (DRUG) As of 2026-03-11, Bright Minds Biosciences Inc (DRUG) is exhibiting a Sell technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 5 indicators are flashing buy, while 8 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for DRUG stands at 41.432, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.959, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 30.071 and the Commodity Channel Index (CCI) at -104.305 further confirm a -14.17 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, DRUG is trading above its 60-day moving average of $83.066 and above its 200-day long-term moving average of $56.735. Key price levels to watch include the immediate resistance at $89.66 and strong support at $72.035. A break above $89.66 could signal a bull continuation, while falling below $72.035 may test the next Fibonacci floor at $63.868.

Bright Minds Biosciences Inc (DRUG) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	54.41	63.868	72.035	81.493	89.66	99.118	107.285
Fibonacci	63.868	70.6	74.76	81.493	88.225	92.385	99.118

Bright Minds Biosciences Inc (DRUG) Technical Indicators

2026-03-11

Name	Value
RSI_14	41.432
STOCHk_14_3_3	30.071
STOCHd_14_3_3	29.791
CCI_20	-104.305
AO_5_34	-2.835
MOM_10	-14.17
MACD_12_26_9	-0.959

Bright Minds Biosciences Inc (DRUG) Relative Strength Index (RSI) is 41.432, creating a Neutral signal.

Bright Minds Biosciences Inc (DRUG) Stochastic Oscillator is 30.071, creating a Neutral signal.

Bright Minds Biosciences Inc (DRUG) Stochastic RSI is 29.791, creating a Neutral signal.

Bright Minds Biosciences Inc (DRUG) Commodity Channel Index (CCI) is -104.305, creating a Buy signal.

Bright Minds Biosciences Inc (DRUG) Awesome Oscillator is -2.835, creating a Sell signal.

Bright Minds Biosciences Inc (DRUG) Momentum is -14.17, creating a Sell signal.

Bright Minds Biosciences Inc (DRUG) MACD is -0.959, creating a Sell signal.

Bright Minds Biosciences Inc (DRUG) Moving Average

2026-03-11

Period	Simple	Signal
MA_5	78.118	Sell
MA_10	80.203	Sell
MA_20	81.989	Sell
MA_60	83.066	Sell
MA_200	56.735	Buy
MA_250	51.949	Buy

Bright Minds Biosciences Inc (DRUG) 5-Day simple moving average is 78.118, while Bright Minds Biosciences Inc (DRUG) share price is $75.83, making it a Sell.

Bright Minds Biosciences Inc (DRUG) 10-Day simple moving average is 80.203, while Bright Minds Biosciences Inc (DRUG) share price is $75.83, making it a Sell.

Bright Minds Biosciences Inc (DRUG) 20-Day simple moving average is 81.989, while Bright Minds Biosciences Inc (DRUG) share price is $75.83, making it a Sell.

Bright Minds Biosciences Inc (DRUG) 60-Day simple moving average is 83.066, while Bright Minds Biosciences Inc (DRUG) share price is $75.83, making it a Sell.

Bright Minds Biosciences Inc (DRUG) 200-Day simple moving average is 56.735, while Bright Minds Biosciences Inc (DRUG) share price is $75.83, making it a Buy.

Bright Minds Biosciences Inc (DRUG) 250-Day simple moving average is 51.949, while Bright Minds Biosciences Inc (DRUG) share price is $75.83, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for DRUG?

The overall technical consensus for Bright Minds Biosciences Inc (DRUG) is currently Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 4 sell signals.

What are the key support and resistance levels for Bright Minds Biosciences Inc (DRUG) today?

Based on pivot point calculations, Bright Minds Biosciences Inc (DRUG) has an immediate support level at 72.035 and a major resistance level at 89.66. Traders also monitor the pivot point at 81.493 to determine the intraday trend direction.

Is Bright Minds Biosciences Inc (DRUG) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Bright Minds Biosciences Inc (DRUG) is currently 41.432. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Bright Minds Biosciences Inc (DRUG)?

Bright Minds Biosciences Inc (DRUG) Moving Averages Convergence Divergence (MACD) indicator is -0.959, suggesting DRUG is Sell. This indicator helps identify potential trend reversals or momentum shifts for Bright Minds Biosciences Inc.

How is Bright Minds Biosciences Inc (DRUG) performing relative to its 200-day moving average?

Bright Minds Biosciences Inc (DRUG) is currently trading at $75.83, which is above its 200-day simple moving average of 56.735. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.